CFL2 Gene Nemaline Myopathy Type 7 Genetic Test
Are you concerned about the possibility of having nemaline myopathy type 7? DNA Labs UAE offers the CFL2 Gene Nemaline Myopathy Type 7 Genetic Test to provide you with valuable information about your genetic makeup. Let’s dive into the details of this test.
Test Components and Price
The CFL2 Gene Nemaline Myopathy Type 7 Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Method
After the sample is collected, the report will be delivered to you within 3 to 4 weeks. The test utilizes NGS (Next-Generation Sequencing) technology to analyze the CFL2 gene for mutations or variations associated with nemaline myopathy type 7.
Test Type and Doctor
The CFL2 Gene Nemaline Myopathy Type 7 Genetic Test falls under the category of Neurological Disorders. It is recommended to consult a neurologist for this test.
Test Department and Pre-Test Information
The test is conducted by the Genetics department. Before undergoing the CFL2 Gene Nemaline Myopathy Type 7 NGS Genetic DNA Test, it is essential to provide the clinical history of the patient. Additionally, a genetic counseling session is recommended to draw a pedigree chart of family members affected by CFL2 Gene Nemaline Myopathy Type 7.
Understanding the Test
Nemaline myopathy is a rare genetic muscle disorder characterized by muscle weakness, low muscle tone, and the presence of nemaline bodies (abnormal protein aggregates) in muscle fibers. The CFL2 gene provides instructions for producing a protein called cofilin-2, which regulates the structure and function of muscle cells. Mutations in the CFL2 gene have been linked to nemaline myopathy type 7.
The CFL2 Gene Nemaline Myopathy Type 7 NGS Genetic Test involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual being tested. NGS technology is then used to analyze the entire coding region of the CFL2 gene, enabling the detection of any mutations or variations. The results of this test can confirm a diagnosis of nemaline myopathy type 7 and provide information about the specific genetic variant causing the condition.
Implications of the Test Results
The CFL2 Gene Nemaline Myopathy Type 7 NGS Genetic Test results are valuable for genetic counseling, family planning, and potentially guiding treatment decisions in the future.
By undergoing this test, you can gain a deeper understanding of your genetic makeup and make informed decisions about your health. If you suspect nemaline myopathy type 7, consider taking the CFL2 Gene Nemaline Myopathy Type 7 Genetic Test offered by DNA Labs UAE.
| Test Name | CFL2 Gene Nemaline myopathy type 7 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CFL2 Gene Nemaline myopathy type 7 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CFL2 Gene Nemaline myopathy type 7 |
| Test Details |
CFL2 gene nemaline myopathy type 7 NGS genetic test is a genetic test that uses next-generation sequencing (NGS) technology to analyze the CFL2 gene for mutations or variations that may be associated with nemaline myopathy type 7. Nemaline myopathy is a rare genetic muscle disorder characterized by muscle weakness, low muscle tone, and the presence of nemaline bodies (abnormal protein aggregates) in muscle fibers. There are several different types of nemaline myopathy, each caused by mutations in different genes. The CFL2 gene provides instructions for making a protein called cofilin-2, which plays a role in regulating the structure and function of muscle cells. Mutations in the CFL2 gene have been identified in individuals with nemaline myopathy type 7. The CFL2 gene nemaline myopathy type 7 NGS genetic test involves obtaining a DNA sample, usually through a blood sample or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to analyze the entire coding region of the CFL2 gene. This allows for the detection of any mutations or variations that may be present. The results of the CFL2 gene nemaline myopathy type 7 NGS genetic test can help confirm a diagnosis of nemaline myopathy type 7 and provide information about the specific genetic variant causing the condition. This information can be used for genetic counseling, family planning, and potentially for guiding treatment decisions in the future. |
